Psilocybin therapeutic use program established; protections for registered patients, designated cultivators, registered facilitators, and health care practitioners established; rulemaking authorized; civil actions authorized; fees established; advisory committee established; criminal penalties provided; and money appropriated.

What happened: A Minnesota bill, with an author recently added, would formally establish a psilocybin therapeutic use program including protections for registered patients, designated cultivators, registered facilitators, and health care practitioners, along with rulemaking authority, civil action provisions, fees, an advisory committee, criminal penalties, and appropriations.

Why it matters: The comprehensive regulatory framework would define cultivation, testing, and facilitation requirements, shaping how businesses and practitioners may legally operate within the psilocybin therapeutic space.

Affects: cultivators and labs and patients